Japanese shares rose to a two-week high on Friday as the weaker yen lifted exporters, while renewed fears about the spread of the Ebola virus in the United States bolstered Ebola-related stocks such as Fujifilm Holdings Corp.
The Nikkei share average ended 1% higher to 15,291.64, the best closing level since Oct 10.
For the week, the index gained 5.2%.
Tokyo-listed shares in firms manufacturing Ebola-related products jumped in response to news that a New York City doctor who had worked with the humanitarian organization Doctors Without Borders in Africa became the first person to test positive for the virus in America's largest city.
Air filter manufacturer Airtech Japan Ltd leapt 17%, while health protection device maker Shigematsu Works Co Ltd soared 10%.
Fujifilm, which makes the Avigan drug hoped to be a potential cure for the deadly virus, also rose 2.5%.
The yen was at 107.97 against the dollar, pulling away from two-week lows hit early on Friday as US stock futures tumbled on reports of the New York Ebola diagnosis.
The depreciation of the Japanese currency helped export shares, with Toyota Motor Corp jumping 1.8% and Tokyo Electron Ltd rising 1.2%.
The broader Topix rose 0.8% to 1,242.32, while the JPX-Nikkei Index 400 also advanced 0.9% to 11,308.95.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)